---
title: "VIZZ"
aliases: ["LNZ100", "–∞—Ü–µ–∫–ª–∏–¥–∏–Ω", "aceclidine ophthalmic solution", "–ø—Ä–µ—Å–±–∏–æ–ø–∏—á–µ—Å–∫–∏–µ –∫–∞–ø–ª–∏"]
PubChem CID: 1979
CAS: 827-61-2
description: "–ü–µ—Ä–≤—ã–µ –∏ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–µ FDA-–æ–¥–æ–±—Ä–µ–Ω–Ω—ã–µ –≥–ª–∞–∑–Ω—ã–µ –∫–∞–ø–ª–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞—Ü–µ–∫–ª–∏–¥–∏–Ω–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤–æ–∑—Ä–∞—Å—Ç–Ω–æ–π –ø—Ä–µ—Å–±–∏–æ–ø–∏–∏ —Å —ç—Ñ—Ñ–µ–∫—Ç–æ–º –¥–æ 10 —á–∞—Å–æ–≤"
category: "–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã"
tags: ["–ø—Ä–µ—Å–±–∏–æ–ø–∏—è", "–∞—Ü–µ–∫–ª–∏–¥–∏–Ω", "–∑—Ä–µ–Ω–∏–µ", "–≥–ª–∞–∑–Ω—ã–µ –∫–∞–ø–ª–∏", "FDA", "–º—É—Å–∫–∞—Ä–∏–Ω–æ–≤—ã–µ —Ä–µ—Ü–µ–ø—Ç–æ—Ä—ã", "–º–∏–æ–∑"]
publishedAt: "2025-08-08"
---

# –í–∞—à–µ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –ø–æ VIZZ: –ø—Ä–æ—Ä—ã–≤–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –¥–ª—è –≤–æ–∑—Ä–∞—Å—Ç–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º —Å–æ –∑—Ä–µ–Ω–∏–µ–º

VIZZ ‚Äî —ç—Ç–æ —Ä–µ–≤–æ–ª—é—Ü–∏–æ–Ω–Ω—ã–µ –≥–ª–∞–∑–Ω—ã–µ –∫–∞–ø–ª–∏, —Å—Ç–∞–≤—à–∏–µ –ø–µ—Ä–≤—ã–º –∏ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º FDA-–æ–¥–æ–±—Ä–µ–Ω–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞—Ü–µ–∫–ª–∏–¥–∏–Ω–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø—Ä–µ—Å–±–∏–æ–ø–∏–∏, –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—â–∏–º —É–ª—É—á—à–µ–Ω–∏–µ –±–ª–∏–∂–Ω–µ–≥–æ –∑—Ä–µ–Ω–∏—è –Ω–∞ —Å—Ä–æ–∫ –¥–æ 10 —á–∞—Å–æ–≤.

## –ß—Ç–æ —Ç–∞–∫–æ–µ VIZZ?

**VIZZ** (–∞—Ü–µ–∫–ª–∏–¥–∏–Ω –æ—Ñ—Ç–∞–ª—å–º–∏—á–µ—Å–∫–∏–π —Ä–∞—Å—Ç–≤–æ—Ä 1,44%) ‚Äî —ç—Ç–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –∫–æ–º–ø–∞–Ω–∏–µ–π LENZ Therapeutics –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤–æ–∑—Ä–∞—Å—Ç–Ω–æ–π –ø—Ä–µ—Å–±–∏–æ–ø–∏–∏ —É –≤–∑—Ä–æ—Å–ª—ã—Ö. –≠—Ç–æ –ø–µ—Ä–≤—ã–π –≥–ª–∞–∑–Ω–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞—Ü–µ–∫–ª–∏–¥–∏–Ω–∞, –ø–æ–ª—É—á–∏–≤—à–∏–π –æ–¥–æ–±—Ä–µ–Ω–∏–µ FDA.

–ü—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–æ–±–æ–π —Å—Ç–µ—Ä–∏–ª—å–Ω—ã–π —Ä–∞—Å—Ç–≤–æ—Ä –±–µ–∑ –∫–æ–Ω—Å–µ—Ä–≤–∞–Ω—Ç–æ–≤ –≤ –æ–¥–Ω–æ—Ä–∞–∑–æ–≤—ã—Ö —Ñ–ª–∞–∫–æ–Ω–∞—Ö –¥–ª—è –µ–∂–µ–¥–Ω–µ–≤–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è. –ê–∫—Ç–∏–≤–Ω–æ–µ –≤–µ—â–µ—Å—Ç–≤–æ ‚Äî –∞—Ü–µ–∫–ª–∏–¥–∏–Ω –≥–∏–¥—Ä–æ—Ö–ª–æ—Ä–∏–¥ –≤ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏ 1,44% (—ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç 1,75% –∞—Ü–µ–∫–ª–∏–¥–∏–Ω–∞).

**–ò—Å—Ç–æ—Ä–∏—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏:** VIZZ –±—ã–ª –æ–¥–æ–±—Ä–µ–Ω FDA 31 –∏—é–ª—è 2025 –≥–æ–¥–∞ –ø–æ—Å–ª–µ —É—Å–ø–µ—à–Ω–æ–≥–æ –∑–∞–≤–µ—Ä—à–µ–Ω–∏—è –ø—Ä–æ–≥—Ä–∞–º–º—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π CLARITY. –≠—Ç–æ —Å—Ç–∞–ª–æ –≥–ª–æ–±–∞–ª—å–Ω—ã–º –ø—Ä–æ—Ä—ã–≤–æ–º –≤ –ª–µ—á–µ–Ω–∏–∏ –ø—Ä–µ—Å–±–∏–æ–ø–∏–∏ –∏ –Ω–æ–≤–æ–π –≤–µ—Ö–æ–π –≤ –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏–∏.

‚ö†Ô∏è **–í–∞–∂–Ω–æ–µ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ:**
VIZZ —è–≤–ª—è–µ—Ç—Å—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º —Å—Ä–µ–¥—Å—Ç–≤–æ–º, –æ—Ç–ø—É—Å–∫–∞–µ–º—ã–º –ø–æ —Ä–µ—Ü–µ–ø—Ç—É. –ò–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –≤ –¥–∞–Ω–Ω–æ–π —Å—Ç–∞—Ç—å–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –≤ –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö —Ü–µ–ª—è—Ö –∏ –Ω–µ –¥–æ–ª–∂–Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –¥–ª—è —Å–∞–º–æ–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏–ª–∏ —Å–∞–º–æ–ª–µ—á–µ–Ω–∏—è. –ü—Ä–∏—ë–º –ª—é–±—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤–æ–∑–º–æ–∂–µ–Ω —Ç–æ–ª—å–∫–æ –ø–æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—é –≤—Ä–∞—á–∞. –°–∞–º–æ–ª–µ—á–µ–Ω–∏–µ –º–æ–∂–µ—Ç –±—ã—Ç—å –æ–ø–∞—Å–Ω—ã–º –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è.

## –ö–ª—é—á–µ–≤—ã–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –∏ –æ–±–ª–∞—Å—Ç–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è

–ù–∞ –æ—Å–Ω–æ–≤–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π VIZZ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –¥–ª—è:

- **–ö–æ—Ä—Ä–µ–∫—Ü–∏—è –ø—Ä–µ—Å–±–∏–æ–ø–∏–∏**: –£–ª—É—á—à–∞–µ—Ç –±–ª–∏–∂–Ω–µ–µ –∑—Ä–µ–Ω–∏–µ —É –≤–∑—Ä–æ—Å–ª—ã—Ö —Å –≤–æ–∑—Ä–∞—Å—Ç–Ω—ã–º–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è–º–∏ –∑—Ä–µ–Ω–∏—è
- **–≠—Ñ—Ñ–µ–∫—Ç ¬´–ø–∏–Ω—Ö–æ–ª–∞¬ª**: –°–æ–∑–¥–∞—ë—Ç —Å—É–∂–µ–Ω–∏–µ –∑—Ä–∞—á–∫–∞ –º–µ–Ω–µ–µ 2 –º–º –¥–ª—è —É–≤–µ–ª–∏—á–µ–Ω–∏—è –≥–ª—É–±–∏–Ω—ã —Ñ–æ–∫—É—Å–∞
- **–î–ª–∏—Ç–µ–ª—å–Ω–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ**: –û–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç —É–ª—É—á—à–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è –Ω–∞ —Å—Ä–æ–∫ –¥–æ 10 —á–∞—Å–æ–≤ –ø–æ—Å–ª–µ –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è
- **–ë—ã—Å—Ç—Ä–æ–µ –Ω–∞—á–∞–ª–æ –¥–µ–π—Å—Ç–≤–∏—è**: –≠—Ñ—Ñ–µ–∫—Ç –ø—Ä–æ—è–≤–ª—è–µ—Ç—Å—è –≤ —Ç–µ—á–µ–Ω–∏–µ 30 –º–∏–Ω—É—Ç –ø–æ—Å–ª–µ –∑–∞–∫–∞–ø—ã–≤–∞–Ω–∏—è
- **–ú–µ—Ö–∞–Ω–∏–∑–º –¥–µ–π—Å—Ç–≤–∏—è**: –°–µ–ª–µ–∫—Ç–∏–≤–Ω–æ –≤–æ–∑–¥–µ–π—Å—Ç–≤—É–µ—Ç –Ω–∞ —Å—Ñ–∏–Ω–∫—Ç–µ—Ä –∑—Ä–∞—á–∫–∞ –ø—Ä–∏ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–º –≤–ª–∏—è–Ω–∏–∏ –Ω–∞ —Ü–∏–ª–∏–∞—Ä–Ω—É—é –º—ã—à—Ü—É, –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞—è –º–∏–æ–ø–∏—á–µ—Å–∫–∏–π —Å–¥–≤–∏–≥

## –ù–∞—É—á–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ: —á—Ç–æ –≥–æ–≤–æ—Ä—è—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è?

**–ö—Ä–∞—Ç–∫–æ–µ –∏–∑–ª–æ–∂–µ–Ω–∏–µ:**
–≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å VIZZ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∞ —Ç—Ä–µ–º—è —Ä–∞–Ω–¥–æ–º–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏, –¥–≤–æ–π–Ω—ã–º–∏ —Å–ª–µ–ø—ã–º–∏, –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏ III —Ñ–∞–∑—ã –ø—Ä–æ–≥—Ä–∞–º–º—ã CLARITY —Å —É—á–∞—Å—Ç–∏–µ–º –±–æ–ª–µ–µ 1000 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤.

**–ù–∞–¥–µ–∂–Ω–æ—Å—Ç—å –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤:** –≤—ã—Å–æ–∫–∞—è (–æ—Å–Ω–æ–≤–∞–Ω–∞ –Ω–∞ –∫—Ä—É–ø–Ω—ã—Ö —Ä–∞–Ω–¥–æ–º–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö III —Ñ–∞–∑—ã)

**–ö–ª—é—á–µ–≤—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã:**
- 71% —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –¥–æ—Å—Ç–∏–≥–ª–∏ —É–ª—É—á—à–µ–Ω–∏—è –Ω–∞ 3 —Å—Ç—Ä–æ–∫–∏ –∏ –±–æ–ª–µ–µ —á–µ—Ä–µ–∑ 30 –º–∏–Ω—É—Ç –∏ 3 —á–∞—Å–∞
- 40% —Å–æ—Ö—Ä–∞–Ω—è–ª–∏ —É–ª—É—á—à–µ–Ω–∏–µ –Ω–∞ 3 —Å—Ç—Ä–æ–∫–∏ —á–µ—Ä–µ–∑ 10 —á–∞—Å–æ–≤
- 95% —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ø–æ–∫–∞–∑–∞–ª–∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º–æ–µ —É–ª—É—á—à–µ–Ω–∏–µ –Ω–∞ 2 —Å—Ç—Ä–æ–∫–∏ —á–µ—Ä–µ–∑ 1 —á–∞—Å
- –£–ª—É—á—à–µ–Ω–∏–µ –¥–∞–ª—å–Ω–µ–≥–æ –∑—Ä–µ–Ω–∏—è –Ω–∞ 2-4 –±—É–∫–≤—ã –ø—Ä–∏ –Ω–æ—Ä–º–∞–ª—å–Ω–æ–º –æ—Å–≤–µ—â–µ–Ω–∏–∏
- –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Å–µ—Ä—å—ë–∑–Ω—ã—Ö –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω—ã—Ö —è–≤–ª–µ–Ω–∏–π –∑–∞ –±–æ–ª–µ–µ —á–µ–º 30 000 –¥–Ω–µ–π –ª–µ—á–µ–Ω–∏—è

**–°—Å—ã–ª–∫–∏ –Ω–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è:**
- –ü–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π CLARITY —Ñ–∞–∑—ã III –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø—Ä–µ—Å–±–∏–æ–ø–∏–∏ - [LENZ Therapeutics, 2024](https://ir.lenz-tx.com/news-events/press-releases/detail/11/lenz-therapeutics-announces-positive-topline-data-from-phase-3-clarity-presbyopia-trials)
- –û–¥–æ–±—Ä–µ–Ω–∏–µ FDA –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ VIZZ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø—Ä–µ—Å–±–∏–æ–ø–∏–∏ - [FDA, 2025](https://ir.lenz-tx.com/news-events/press-releases/detail/39/lenz-therapeutics-announces-us-fda-approval-of-vizz-for-the-treatment-of-presbyopia)
- –ü–æ—Å–ª–µ–¥–Ω–∏–µ –¥–∞–Ω–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∞—Ü–µ–∫–ª–∏–¥–∏–Ω–∞ CLARITY - [Presbyopia Physician, 2024](https://www.presbyopiaphysician.com/issues/2024/june/aceclidine/)

## –ö–∞–∫ –ø—Ä–∏–Ω–∏–º–∞—Ç—å VIZZ

### –†–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω—ã–µ —Ñ–æ—Ä–º—ã:
- **–û–¥–Ω–æ—Ä–∞–∑–æ–≤—ã–µ —Ñ–ª–∞–∫–æ–Ω—ã**: –°—Ç–µ—Ä–∏–ª—å–Ω—ã–π —Ä–∞—Å—Ç–≤–æ—Ä –±–µ–∑ –∫–æ–Ω—Å–µ—Ä–≤–∞–Ω—Ç–æ–≤ –æ–±—ä—ë–º–æ–º 0,6 –º–ª

### –¢–∏–ø–∏—á–Ω–∞—è –¥–æ–∑–∏—Ä–æ–≤–∫–∞:
- **–°—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–∞—è –¥–æ–∑–∞**: 1 –∫–∞–ø–ª—è –≤ –∫–∞–∂–¥—ã–π –≥–ª–∞–∑, —á–µ—Ä–µ–∑ 2 –º–∏–Ω—É—Ç—ã –ø–æ–≤—Ç–æ—Ä–∏—Ç—å –∑–∞–∫–∞–ø—ã–≤–∞–Ω–∏–µ —Ç–æ–π –∂–µ –¥–æ–∑—ã
- **–ß–∞—Å—Ç–æ—Ç–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è**: –û–¥–∏–Ω —Ä–∞–∑ –≤ –¥–µ–Ω—å
- **–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –¥–µ–π—Å—Ç–≤–∏—è**: –î–æ 10 —á–∞—Å–æ–≤
- **–í—Ä–µ–º—è –Ω–∞—á–∞–ª–∞ –¥–µ–π—Å—Ç–≤–∏—è**: 30 –º–∏–Ω—É—Ç
- –í—Å–µ–≥–¥–∞ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –≤—Ä–∞—á–æ–º.

### –í—Ä–µ–º—è –ø—Ä–∏–µ–º–∞:
- –ü—Ä–∏–º–µ–Ω—è—Ç—å —É—Ç—Ä–æ–º –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –¥–Ω–µ–≤–Ω–æ–π –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏
- –≠—Ñ—Ñ–µ–∫—Ç —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è –≤–µ—Å—å —Ä–∞–±–æ—á–∏–π –¥–µ–Ω—å
- –ü—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –∫–æ–Ω—Ç–∞–∫—Ç–Ω—ã—Ö –ª–∏–Ω–∑ —Å–Ω–∏–º–∞—Ç—å –ø–µ—Ä–µ–¥ –∑–∞–∫–∞–ø—ã–≤–∞–Ω–∏–µ–º
- –ú–æ–∂–Ω–æ –≤—Å—Ç–∞–≤–ª—è—Ç—å –ª–∏–Ω–∑—ã —á–µ—Ä–µ–∑ 10 –º–∏–Ω—É—Ç –ø–æ—Å–ª–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è

### –°–æ–≤–µ—Ç—ã –ø–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é:
- –í—ã–±—Ä–∞—Å—ã–≤–∞—Ç—å —Ñ–ª–∞–∫–æ–Ω —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è
- –ù–µ –∫–∞—Å–∞—Ç—å—Å—è –∫–æ–Ω—á–∏–∫–æ–º —Ñ–ª–∞–∫–æ–Ω–∞ –≥–ª–∞–∑–∞ –∏–ª–∏ –¥—Ä—É–≥–∏—Ö –ø–æ–≤–µ—Ä—Ö–Ω–æ—Å—Ç–µ–π
- –ü—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –¥—Ä—É–≥–∏—Ö –≥–ª–∞–∑–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–æ–±–ª—é–¥–∞—Ç—å –∏–Ω—Ç–µ—Ä–≤–∞–ª 5 –º–∏–Ω—É—Ç
- –•—Ä–∞–Ω–∏—Ç—å –≤ —Ö–æ–ª–æ–¥–∏–ª—å–Ω–∏–∫–µ –ø—Ä–∏ —Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä–µ 2-8¬∞C

## –ü–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–µ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã –∏ –º–µ—Ä—ã –ø—Ä–µ–¥–æ—Å—Ç–æ—Ä–æ–∂–Ω–æ—Å—Ç–∏

–ö–∞–∫ –∏ –ª—é–±–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ, VIZZ –º–æ–∂–µ—Ç –≤—ã–∑—ã–≤–∞—Ç—å –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö –±—ã–ª–∏ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –ª—ë–≥–∫–∏–º–∏ –∏ –≤—Ä–µ–º–µ–Ω–Ω—ã–º–∏.

### –í–æ–∑–º–æ–∂–Ω—ã–µ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã:

**–ß–∞—Å—Ç—ã–µ (–±–æ–ª–µ–µ 10%):**
- –†–∞–∑–¥—Ä–∞–∂–µ–Ω–∏–µ –≤ –º–µ—Å—Ç–µ –∑–∞–∫–∞–ø—ã–≤–∞–Ω–∏—è (20%)
- –ó–∞—Ç–µ–º–Ω–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è (16%)
- –ì–æ–ª–æ–≤–Ω–∞—è –±–æ–ª—å (13%)

**–ú–µ–Ω–µ–µ —á–∞—Å—Ç—ã–µ (5-10%):**
- –ü–æ–∫—Ä–∞—Å–Ω–µ–Ω–∏–µ –∫–æ–Ω—ä—é–Ω–∫—Ç–∏–≤—ã (8%)
- –ü–æ–∫—Ä–∞—Å–Ω–µ–Ω–∏–µ –≥–ª–∞–∑ (7%)

**–†–µ–¥–∫–∏–µ:**
- –û—Ç—Å–ª–æ–π–∫–∞ —Å–µ—Ç—á–∞—Ç–∫–∏ (–æ—á–µ–Ω—å —Ä–µ–¥–∫–æ)
- –ò—Ä–∏–¥–æ—Ü–∏–∫–ª–∏—Ç –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –≤–æ—Å–ø–∞–ª–µ–Ω–∏—è

### –ú–µ—Ä—ã –ø—Ä–µ–¥–æ—Å—Ç–æ—Ä–æ–∂–Ω–æ—Å—Ç–∏:

**–ü—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è:**
- –ê–ª–ª–µ—Ä–≥–∏—è –Ω–∞ –∞—Ü–µ–∫–ª–∏–¥–∏–Ω –∏–ª–∏ –≤—Å–ø–æ–º–æ–≥–∞—Ç–µ–ª—å–Ω—ã–µ –≤–µ—â–µ—Å—Ç–≤–∞
- –û—Å—Ç—Ä—ã–µ –≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –≥–ª–∞–∑

**–û—Å–æ–±—ã–µ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è:**
- –í—Ä–µ–º–µ–Ω–Ω–æ–µ —É—Ö—É–¥—à–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è, –æ—Å–æ–±–µ–Ω–Ω–æ –ø—Ä–∏ —Å–ª–∞–±–æ–º –æ—Å–≤–µ—â–µ–Ω–∏–∏
- –û—Å—Ç–æ—Ä–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏ –≤–æ–∂–¥–µ–Ω–∏–∏ –∞–≤—Ç–æ–º–æ–±–∏–ª—è, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —Ç—ë–º–Ω–æ–µ –≤—Ä–µ–º—è
- –†–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç—Å—è –æ—Å–º–æ—Ç—Ä —Å–µ—Ç—á–∞—Ç–∫–∏ –ø–µ—Ä–µ–¥ –Ω–∞—á–∞–ª–æ–º –ª–µ—á–µ–Ω–∏—è

**–†–µ–≥—É–ª—è—Ç–∏–≤–Ω—ã–π —Å—Ç–∞—Ç—É—Å:** –û–¥–æ–±—Ä–µ–Ω FDA –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞, –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∞—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –æ–∂–∏–¥–∞–µ—Ç—Å—è –≤ Q4 2025
–ü—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –≤—Ä–∞—á–æ–º –ø–µ—Ä–µ–¥ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º.

## –í—ã–±–æ—Ä –ø—Ä–∞–≤–∏–ª—å–Ω–æ–π —Ñ–æ—Ä–º—ã –∏ –∫–∞—á–µ—Å—Ç–≤–∞

### –û—Å–Ω–æ–≤–Ω—ã–µ —Ñ–æ—Ä–º—ã:

**VIZZ 1,44%** - –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–∞—è –¥–æ—Å—Ç—É–ø–Ω–∞—è –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—è, –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –¥–ª—è –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–∏ –º–∏–Ω–∏–º–∞–ª—å–Ω—ã—Ö –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–∞—Ö, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –≤ —Å—Ç–µ—Ä–∏–ª—å–Ω—ã—Ö –æ–¥–Ω–æ—Ä–∞–∑–æ–≤—ã—Ö —Ñ–ª–∞–∫–æ–Ω–∞—Ö.

### –°–æ–≤–µ—Ç—ã –ø–æ –∫–∞—á–µ—Å—Ç–≤—É:

1. **–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å**: LENZ Therapeutics, —Å–µ—Ä—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ FDA –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ
2. **–°—Ç–µ—Ä–∏–ª—å–Ω–æ—Å—Ç—å**: –ü—Ä–µ–ø–∞—Ä–∞—Ç –±–µ–∑ –∫–æ–Ω—Å–µ—Ä–≤–∞–Ω—Ç–æ–≤ –≤ –æ–¥–Ω–æ—Ä–∞–∑–æ–≤—ã—Ö —Ñ–ª–∞–∫–æ–Ω–∞—Ö
3. **–•—Ä–∞–Ω–µ–Ω–∏–µ**: –•–æ–ª–æ–¥–∏–ª—å–Ω–æ–µ —Ö—Ä–∞–Ω–µ–Ω–∏–µ –¥–æ –≤—Å–∫—Ä—ã—Ç–∏—è, –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ø—Ä–∏ –∫–æ–º–Ω–∞—Ç–Ω–æ–π —Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä–µ –≤ —Ç–µ—á–µ–Ω–∏–µ 30 –¥–Ω–µ–π

## –ò–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏ –æ–ø—ã—Ç —Å–æ–æ–±—â–µ—Å—Ç–≤–∞

### –ú–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π:

**Dr. Marc Bloomenstein, OD, FAAO** (Schwartz Laser Eye Care Center): "–≠—Ç–æ –æ–¥–æ–±—Ä–µ–Ω–∏–µ FDA –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–æ–±–æ–π —Ä–µ–≤–æ–ª—é—Ü–∏–æ–Ω–Ω—ã–π —Å–¥–≤–∏–≥ –ø–∞—Ä–∞–¥–∏–≥–º—ã –≤ –≤–∞—Ä–∏–∞–Ω—Ç–∞—Ö –ª–µ—á–µ–Ω–∏—è –¥–ª—è –º–∏–ª–ª–∏–æ–Ω–æ–≤ –ª—é–¥–µ–π, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞—Å—Å—Ç—Ä–æ–µ–Ω—ã –∏ –±–æ—Ä—é—Ç—Å—è —Å –Ω–µ–∏–∑–±–µ–∂–Ω–æ–π –≤–æ–∑—Ä–∞—Å—Ç–Ω–æ–π –ø–æ—Ç–µ—Ä–µ–π –±–ª–∏–∂–Ω–µ–≥–æ –∑—Ä–µ–Ω–∏—è" - [LENZ Therapeutics Press Release, 2025](https://ir.lenz-tx.com/news-events/press-releases/detail/39/lenz-therapeutics-announces-us-fda-approval-of-vizz-for-the-treatment-of-presbyopia)

### –û–ø—ã—Ç —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π:

**–†–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–ø—Ä–æ—Å–∞ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ CLARITY:** 90% —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –æ—Ç–º–µ—Ç–∏–ª–∏ —É–ª—É—á—à–µ–Ω–∏–µ –±–ª–∏–∂–Ω–µ–≥–æ –∑—Ä–µ–Ω–∏—è, 75% –≤—ã—Ä–∞–∑–∏–ª–∏ –∂–µ–ª–∞–Ω–∏–µ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ø–æ—Å–ª–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö 81% –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç 4-7 –¥–Ω–µ–π –≤ –Ω–µ–¥–µ–ª—é - [Optometry Times, 2024](https://www.optometrytimes.com/view/lenz-therapeutics-announces-positive-results-from-phase-3-clarity-trials)

**–û—Ç–∑—ã–≤—ã –æ –ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç–∏:** –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –æ–ø–∏—Å—ã–≤–∞–ª–∏—Å—å —É—á–∞—Å—Ç–Ω–∏–∫–∞–º–∏ –∫–∞–∫ –ª—ë–≥–∫–∏–µ –∏ —Å–∞–º–æ–ø—Ä–æ—Ö–æ–¥—è—â–∏–µ, –ø—Ä–∏ —ç—Ç–æ–º 89% —Å–ª—É—á–∞–µ–≤ –≥–æ–ª–æ–≤–Ω–æ–π –±–æ–ª–∏ –æ—Ü–µ–Ω–∏–≤–∞–ª–∏—Å—å –∫–∞–∫ –ª—ë–≥–∫–∏–µ.

### –ü–æ–ª–µ–∑–Ω—ã–µ —Å–æ–≤–µ—Ç—ã –æ—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π:
- –ü—Ä–∏–º–µ–Ω–µ–Ω–∏–µ —É—Ç—Ä–æ–º –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç –≤ —Ç–µ—á–µ–Ω–∏–µ —Ä–∞–±–æ—á–µ–≥–æ –¥–Ω—è
- –≠—Ñ—Ñ–µ–∫—Ç –Ω–∞–∏–±–æ–ª–µ–µ –≤—ã—Ä–∞–∂–µ–Ω –≤ –ø–µ—Ä–≤—ã–µ —á–∞—Å—ã –ø–æ—Å–ª–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è
- –ü–æ–¥—Ö–æ–¥–∏—Ç –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –ø–æ—Å–ª–µ LASIK –∏ –∫–∞—Ç–∞—Ä–∞–∫—Ç–∞–ª—å–Ω–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏

## –ß–∞—Å—Ç–æ –∑–∞–¥–∞–≤–∞–µ–º—ã–µ –≤–æ–ø—Ä–æ—Å—ã (FAQ)

**–ü—Ä–∞–≤–æ–≤–æ–π —Å—Ç–∞—Ç—É—Å VIZZ –≤ –°–®–ê?**
–û–¥–æ–±—Ä–µ–Ω FDA –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞ –∫–∞–∫ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ö–æ–º–º–µ—Ä—á–µ—Å–∫–∞—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –æ–∂–∏–¥–∞–µ—Ç—Å—è –≤ Q4 2025 –≥–æ–¥–∞.

**–ß–µ—Ä–µ–∑ –∫–∞–∫–æ–µ –≤—Ä–µ–º—è –ø–æ—è–≤–ª—è—é—Ç—Å—è —ç—Ñ—Ñ–µ–∫—Ç—ã?**  
–£–ª—É—á—à–µ–Ω–∏–µ –±–ª–∏–∂–Ω–µ–≥–æ –∑—Ä–µ–Ω–∏—è –Ω–∞—á–∏–Ω–∞–µ—Ç—Å—è —á–µ—Ä–µ–∑ 30 –º–∏–Ω—É—Ç –ø–æ—Å–ª–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, –¥–æ—Å—Ç–∏–≥–∞–µ—Ç –ø–∏–∫–∞ —á–µ—Ä–µ–∑ 1-3 —á–∞—Å–∞ –∏ –¥–ª–∏—Ç—Å—è –¥–æ 10 —á–∞—Å–æ–≤.

**–ú–æ–∂–Ω–æ –ª–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å –∫–æ–Ω—Ç–∞–∫—Ç–Ω—ã–º–∏ –ª–∏–Ω–∑–∞–º–∏?**
–î–∞, –Ω–æ –ª–∏–Ω–∑—ã –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —Å–Ω–∏–º–∞—Ç—å –ø–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –∏ –º–æ–∂–Ω–æ –≤—Å—Ç–∞–≤–ª—è—Ç—å –æ–±—Ä–∞—Ç–Ω–æ —á–µ—Ä–µ–∑ 10 –º–∏–Ω—É—Ç –ø–æ—Å–ª–µ –∑–∞–∫–∞–ø—ã–≤–∞–Ω–∏—è.

**–í–ª–∏—è–µ—Ç –ª–∏ –Ω–∞ —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å —É–ø—Ä–∞–≤–ª—è—Ç—å –∞–≤—Ç–æ–º–æ–±–∏–ª–µ–º?**
–ú–æ–∂–µ—Ç –≤—Ä–µ–º–µ–Ω–Ω–æ —É—Ö—É–¥—à–∞—Ç—å –∑—Ä–µ–Ω–∏–µ –ø—Ä–∏ —Å–ª–∞–±–æ–º –æ—Å–≤–µ—â–µ–Ω–∏–∏. –†–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç—Å—è –æ—Å—Ç–æ—Ä–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏ –≤–æ–∂–¥–µ–Ω–∏–∏, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —Ç—ë–º–Ω–æ–µ –≤—Ä–µ–º—è —Å—É—Ç–æ–∫.

**–°—Ç–æ–∏–º–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è?**
–ü–æ –¥–∞–Ω–Ω—ã–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è, —Å—Ç–æ–∏–º–æ—Å—Ç—å —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç $79 –∑–∞ –º–µ—Å—è—á–Ω—ã–π –∫—É—Ä—Å (25 –¥–æ–∑) –∏–ª–∏ $198 –∑–∞ —Ç—Ä—ë—Ö–º–µ—Å—è—á–Ω—ã–π –∫—É—Ä—Å.

## –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏

1. **–ö–∞–∫ –Ω–∞—á–∏–Ω–∞—Ç—å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ**: –ü–µ—Ä–≤–æ–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –ø–æ–¥ –Ω–∞–±–ª—é–¥–µ–Ω–∏–µ–º –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∞, –æ—Ü–µ–Ω–∫–∞ –ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç–∏ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏

2. **–û–ø—Ç–∏–º–∞–ª—å–Ω–æ–µ –≤—Ä–µ–º—è**: –£—Ç—Ä–µ–Ω–Ω–µ–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è —É–ª—É—á—à–µ–Ω–∏—è –∑—Ä–µ–Ω–∏—è –≤ —Ç–µ—á–µ–Ω–∏–µ —Ä–∞–±–æ—á–µ–≥–æ –¥–Ω—è

3. **–ú–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ —ç—Ñ—Ñ–µ–∫—Ç–æ–≤**: –†–µ–≥—É–ª—è—Ä–Ω—ã–µ –æ—Å–º–æ—Ç—Ä—ã —É –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∞, –∫–æ–Ω—Ç—Ä–æ–ª—å —Å–æ—Å—Ç–æ—è–Ω–∏—è —Å–µ—Ç—á–∞—Ç–∫–∏

4. **–•—Ä–∞–Ω–µ–Ω–∏–µ –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ**: –°–æ–±–ª—é–¥–µ–Ω–∏–µ —Ö–æ–ª–æ–¥–æ–≤–æ–π —Ü–µ–ø–∏, –ø—Ä–∞–≤–∏–ª—å–Ω–∞—è —Ç–µ—Ö–Ω–∏–∫–∞ –∑–∞–∫–∞–ø—ã–≤–∞–Ω–∏—è

5. **–°–æ–≤–º–µ—Å—Ç–∏–º–æ—Å—Ç—å —Å –æ–±—Ä–∞–∑–æ–º –∂–∏–∑–Ω–∏**: –ü–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Å —É—á—ë—Ç–æ–º –≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ —É—Ö—É–¥—à–µ–Ω–∏—è –∑—Ä–µ–Ω–∏—è –ø—Ä–∏ —Å–ª–∞–±–æ–º –æ—Å–≤–µ—â–µ–Ω–∏–∏

üß† –•–æ—Ç–∏—Ç–µ –±–æ–ª—å—à–µ —Å—Ç–∞—Ç–µ–π –∏ —Ä–∞–∑–±–æ—Ä–æ–≤ –æ—Ç –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏—Ö –±–∏–æ—Ö–∞–∫–µ—Ä–æ–≤?
–ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –∫–∞–Ω–∞–ª, —á—Ç–æ–±—ã –Ω–µ –ø—Ä–æ–ø—É—Å—Ç–∏—Ç—å –Ω–æ–≤—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, —Ä–µ–∞–ª—å–Ω—ã–µ –∫–µ–π—Å—ã –∏ –≥–æ—Ç–æ–≤—ã–µ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã ‚Äî –ø–µ—Ä–µ–π—Ç–∏ –≤ [Telegram](https://t.me/braintmind)

## –û—Ç–∫–∞–∑ –æ—Ç –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏

–≠—Ç–æ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–æ —Ç–æ–ª—å–∫–æ –¥–ª—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ü–µ–ª–µ–π –∏ –Ω–µ —è–≤–ª—è–µ—Ç—Å—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–µ–π. –í—Å—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –ø–æ–ª—É—á–µ–Ω–∞ –∏–∑ –æ—Ç–∫—Ä—ã—Ç—ã—Ö –Ω–∞—É—á–Ω—ã—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤, –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∏ –ø—É–±–ª–∏–∫–∞—Ü–∏–π. –í—Å–µ–≥–¥–∞ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–º, –ø—Ä–µ–∂–¥–µ —á–µ–º –Ω–∞—á–∏–Ω–∞—Ç—å –ø—Ä–∏–Ω–∏–º–∞—Ç—å –∫–∞–∫–∏–µ-–ª–∏–±–æ –Ω–æ–≤—ã–µ –¥–æ–±–∞–≤–∫–∏, –æ—Å–æ–±–µ–Ω–Ω–æ –µ—Å–ª–∏ —É –≤–∞—Å –µ—Å—Ç—å —Å–æ–ø—É—Ç—Å—Ç–≤—É—é—â–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏–ª–∏ –≤—ã –ø—Ä–∏–Ω–∏–º–∞–µ—Ç–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞.